SLSN · Solesence
The AI's read
Solesence reported Q2 revenue down to $15.3M but gross margin improved to 31% and backlog/shipped orders total $64.9M, signaling operational improvement despite top-line weakness. Management also flagged inventory-costing restatements that don't affect cash flow, reducing accounting worry. The market barely moved, up ~0.8%, and RSI is 32, so sellers aren't panicking and the headline beat on margin plus a big backlog looks partly priced. Valuation is cheap on a microcap basis, but the revenue decline cancels a clean bull case. Bottom line. We lean neutral. Mixed signals and a small market reaction mean wait for clearer execution or follow-through before leaning bullish in size.